Have a personal or library account? Click to login
The Prevalence and Distribution of High Risk Human Papillomavirus Genotypes in Patients with Dysplastic Lesions: a Population Study Cover

The Prevalence and Distribution of High Risk Human Papillomavirus Genotypes in Patients with Dysplastic Lesions: a Population Study

Acta Marisiensis - Seria Medica
Volume 61 (2015): Issue 4 (December 2015)
By: Voidăzan Septimiu,  Morariu Silviu-Horia,  Căpâlnă Mihai,  Mărginean Claudiu and  Dobreanu Minodora  
Open Access
|Jan 2016

References

  1. 1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2013. Available: http://globocan.iarc.fr.
    Search in Google Scholar
  2. 2. International Agency for Research on Cancer. GLOBOCAN 2012: Cancer Incidence and Mortality Worldwide. Available: http://globocan.iarc.fr.
    Search in Google Scholar
  3. 3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of pathology. 1999;189:12-19.10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
    Search in Google Scholar
  4. 4. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–265.10.1136/jcp.55.4.244
    Search in Google Scholar
  5. 5. Van Doorslaer K, Tan Q, Xirasagar S, et al. The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res. 2013;41:571–578. http://dx.doi.org/10.1093/nar/gks984.
    Search in Google Scholar
  6. 6. de Villiers EM. Cross-roads in the classification of papillomaviruses. Virology. 2013;445:2–10. http://dx.doi.org/10.1016/j.virol.2013.04.023.
    Search in Google Scholar
  7. 7. Bernard HU, Burk RD, Chen Z, et al. Classification of papillomaviruses based on 189 HPV types and proposal of taxonomic amendments. Virology. 2010;401:70–79. http://dx.doi.org/10.1016/j.virol.2010.02.002.
    Search in Google Scholar
  8. 8. Yingfei Ma, Ramana Madupu, Ulas Karaoz, et al. Human Papillomavirus Community in Healthy Persons, Defined by Metagenomics Analysis of Human Microbiome Project Shotgun Sequencing Data Sets, Journal of Virology. 2014;88(9):4786–4797.
    Search in Google Scholar
  9. 9. Boumba AL, Hilali L, Mouallif M, Moukassa D, Mustapha EM: Specific genotypes of human papillomavirus in 125 high-grade squamous lesions and invasive cervical cancer cases from Congolese women, BMC Public Health. 2014;14:1320 doi:10.1186/1471-2458-14-132010.1186/1471-2458-14-1320
    Search in Google Scholar
  10. 10. Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103:1–16.10.1093/jnci/djq562
    Search in Google Scholar
  11. 11. Moga MA, Irimie M, Oanta A, Pascu A, Burtea V. Type-specific prevalence of human papillomavirus by cervical cytology among women in Brasov, Romania, Asian Pac J Cancer Prev. 2014;15(16):6887-6892.
    Search in Google Scholar
  12. 12. Ursu et al. HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania. Virology Journal. 2011;8:558-564. Doi:10.1186/1743-422X-8-55810.1186/1743-422X-8-558
    Search in Google Scholar
  13. 13. Gabriela Anton, Gheorghe Peltecu, Demetra Socolov, et al. Type-specific human papillomavirus detection in cervical smears in Romania, APMIS. 2011;119(1):1-9.doi:10.1111/j.1600-0463.2010.02641.x.10.1111/j.1600-0463.2010.02641.x
    Search in Google Scholar
  14. 14. http://www.mures.insse.ro/main.php
    Search in Google Scholar
  15. 15. Poljak M, Seme K, Maver PJ, et al. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe. Vaccine. 2013;31(31)Suppl7:H59-70.doi: 10.1016/j.vaccine.2013.03.029.10.1016/j.vaccine.2013.03.029
    Search in Google Scholar
  16. 16. Tachezy R, Smahelova J, Salakova M, et al. Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS One. 2011;6:e21913.10.1371/journal.pone.0021913
    Search in Google Scholar
  17. 17. Kovanda A, Juvan U, Sterbenc A, et al. Prevaccination distribution of human papillomavirus (HPV) genotypes in women with cervical intraepithelial neoplasia grade 3 (CIN 3) lesions in Slovenia. Acta Dermatovenerol Alp Panonica Adriat.2009;18:47–52.
    Search in Google Scholar
  18. 18. Ni Li, Silvia Franceschi, Rebecca Howell-Jones, Peter J.F. Snijders, Gary M. Clifford. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication Int. J. Cancer. 2011;128:927–935
    Search in Google Scholar
  19. 19. Haghshenas M, Golini-moghaddam T, Rafiei A, et al. Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a opulation-based study. Infect Agents Cancer. 2013;8 (1):20.10.1186/1750-9378-8-20
    Search in Google Scholar
  20. 20. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. New Engl J Med.1998; 338(7):423–428.10.1056/NEJM199802123380703
    Search in Google Scholar
  21. 21. Rodríguez AC, Schiffman M, Herrero R, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 2010;102(5):315–324.10.1093/jnci/djq001
    Search in Google Scholar
  22. 22. Teitelman AM, Stringer M, Averbuch T, Witkoski A. Human papillomavirus, current vaccines, and cervical cancer prevention. J Obstet Gynecol Neonatal Nurs. 2009;38(1):69–80.10.1111/j.1552-6909.2008.00304.x
    Search in Google Scholar
  23. 23. Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367(9518):1247–1255.10.1016/S0140-6736(06)68439-0
    Search in Google Scholar
  24. 24. Aggarwal P. Cervical cancer: Can it be prevented? World J Clin Oncol. 2014;5(4):775-780 Available: URL: http://www.wjgnet.com/2218-4333/full/v5/i4/775.htm DOI: http://dx.doi.org/10.5306/wjco.v5.i4.775.412954025302177
    Search in Google Scholar
  25. 25. International Agency for Research on Cancer Human Papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2011;100:1–475
    Search in Google Scholar
  26. 26. Miksis S. A review of the evidence comparing the human papillomavirus vaccine versus condoms in the prevention of human papillomavirus infections. J Obstet Gynecol Neonatal Nurs. 2008;37:329–33710.1111/j.1552-6909.2008.00236.x18507603
    Search in Google Scholar
DOI: https://doi.org/10.1515/amma-2015-0107 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 314 - 319
Submitted on: Aug 3, 2015
|
Accepted on: Sep 5, 2015
|
Published on: Jan 19, 2016
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Human papillomavirus,
cervical cancer,
HPV genotype
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2016 Voidăzan Septimiu, Morariu Silviu-Horia, Căpâlnă Mihai, Mărginean Claudiu, Dobreanu Minodora, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 61 (2015): Issue 4 (December 2015)Next article